AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
CRISPR, Gene Therapies, and Cure Pricing Conundrums
Motley Fool Money
How Do You Approach Investing in Ingene Therapy Companies?
3min Snip
00:00
Summary
Transcript
Episode notes
bluebird byo ran into trouble with the european government with regard to pracing a drug, for a drug called scysona. They were wanted to charge one oint eight million for it. Germany was like, no, will pay around 800 thousand. And they could never come to an agreement. Finally, just, finally, just withdrew and then scison o, the drug you mentioned, for a much rarer disease.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode